私たちは、人々が好きな有名人について読んで、それについて気分を良くすることができるスペースを作りたかったのです.私たちは、人々が有名人についてポジティブな方法でゴシップできる場所を作りたかった.
私たちは、何年もの間、日本のエンターテインメント ニュースを生き、呼吸してきた情熱的なエンターテインメント ニュース ジャンキーの小さなチームです。
私たちは、有名人の最新のゴシップを分析し、日本のポップ カルチャーの最新トレンドを分析することを何よりも愛しています。私たちはエンターテインメントのすべてに夢中になっており、私たちの情熱を世界と共有したいと考えています。当サイトへようこそ！
pfizer vaccine, /pfizer-vaccine,
Video: Pfizer Testing New RSV Vaccine
私たちは、人々が好きな有名人について読んで、それについて気分を良くすることができるスペースを作りたかったのです.私たちは、人々が有名人についてポジティブな方法でゴシップできる場所を作りたかった.
私たちは、何年もの間、日本のエンターテインメント ニュースを生き、呼吸してきた情熱的なエンターテインメント ニュース ジャンキーの小さなチームです。
pfizer vaccine, 2022-11-01, Pfizer Testing New RSV Vaccine, Pfizer Testing New RSV Vaccine, KCAU-TV Sioux City
,
Call Center
■MHLW COVID-19 Vaccine Call Center(Every day including weekends and holidays)
・Domestic Calls：0120-761-770（Toll Free）
・From Overseas：（+81）50-3734-0348（Calls will be charged）
-English, Chinese, Korean, Portuguese and Spanish: 9:00-21:00（JST） ／ Thai: 9:00-18:00（JST） ／ Vietnamese: 10:00-19:00（JST）
■FRESC Help Desk (Monday-Friday 9:00-17:00) PDF
・Domestic Calls：0120-76-2029（Toll Free）
-Vietnamese, Chinese, English, Korean, Spanish, Portuguese, Nepali, Thai, Indonesian, Filipino, Myanmar, Khmer(Cambodian), Mongolian, French, Sinhala, Urdu, Bengali
ページの先頭へ戻る
How to get vaccines
Receive a “Vaccination voucher” and a “COVID-19 vaccine notification”
You will receive a “Vaccination voucher” and a “COVID-19 vaccine notification” from the municipalities.
※The costs of vaccination is free for all Japanese citizens and all eligible foreign residents in Japan.
（Image: sample of vaccination voucher）
Find available vaccination sites
You may find a medical institution or vaccination site for your COVID-19 vaccine from municipal website, newsletters and “Vaccine Navi” web in Japanese, Yasashii-Nihongo, English and Chinese.
Make a reservation by phone or online
You will be able to make a reservation for your first vaccination dose by phone or online. “Vaccine Navi” web will help you to find the phone number and the online reservation sites. Please check the availability before making a reservation.
Booster Shots (3rd Dose)
Guide for who and how to receive the booster shots
ページの先頭へ戻る
プレスリリース
-
2022/10/13
ファイザーとビオンテック、日本において5～11歳の小児に対するCOVID-19の2価ワクチン（起源株／オミクロン株BA.4-5）を承認申請
-
2022/10/5
ファイザーとビオンテック、COVID-19ワクチン『コミナティ筋注 6ヵ月～4歳用』および『コミナティRTU筋注（2価：起源株／オミクロン株BA.4-5）』日本における承認取得
-
2022/9/28
第三回ファイザーヘルスケア・ハブ・ジャパン ピッチイベントを開催
- プレスリリース一覧
- 米ファイザー本社プレスリリース一覧（英語）
- RSSについて
- RSS
お知らせ
-
ファイザー新型コロナワクチン 添付文書改訂に関する更新情報（10/20）
-
うつ病・うつ状態治療剤「アモキサンカプセル」「同・細粒」 処方医薬品切り替えに関する患者様へのご案内（10/11）
-
ファイザー新型コロナワクチン 追加供給に関する合意について（3/16）
-
「PRIDE指標2021」 最高位「ゴールド」を受賞
-
『チャンピックス®錠』供給に関する情報
-
米国ファイザー社 会長兼CEO Albert Bourlaからの公開書簡
-
臨床試験への新型コロナウイルス感染症の影響について
- お知らせ一覧
ご挨拶
代表取締役社長のメッセージをご覧いただけます。
会社概要
会社情報や役員、関連会社に関する情報を紹介しています。
企業目的・Values & Behaviors・事業概要
企業目的、Values & Behaviors、事業概要を 紹介しています。
ダイバーシティ、エクイティ＆インクルージョン
ダイバーシティ＆インクルージョンについて紹介しています。
環境への取り組み
環境・安全・健康方針、環境活動を紹介しています。
- ファイザー環境・健康・安全（EHS）スタンダード
- 名古屋工場の活動に伴う環境影響評価
- 名古屋工場の環境目標と達成状況
コンプライアンスの
取り組み
企業活動と医療機関等の関係の透明性への取り組みについて紹介しています。
- 企業活動と医療機関等の関係の透明性への取り組み
- 企業活動と患者団体の関係の透明性への取り組み
ファイザー日本法人最新の
取り組み
ファイザー日本法人最新の取り組みについて紹介しています。
ファイザー製品の品質への
取り組み
ファイザー製品の品質への取り組みについて紹介しています。
Types of COVID-19 Vaccines Available
There are four approved or authorized vaccines in the United States.
- Pfizer-BioNTech and Moderna COVID-19 vaccines are mRNA vaccines.
- Novavax COVID-19 vaccine is a protein subunit vaccine.
- Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 vaccine is a viral vector vaccine and can be given in some situations.
These vaccines are given as a shot in the muscle of the upper arm or in the thigh of a young child. COVID-19 vaccine ingredients are considered safe for most people. Nearly all of the ingredients in COVID-19 vaccines are ingredients found in many foods—fats, sugar, and salts. None of the COVID-19 vaccines affect or interact with our DNA and the following are not included in the vaccines:
- No preservatives such as thimerosal or mercury or any other preservatives.
- No antibiotics such as sulfonamide or any other antibiotics.
- No medicines or therapeutics such as ivermectin or any other medications.
- No tissues such as aborted fetal cells, gelatin, or any materials from any animal.
- No food proteins such as eggs or egg products, gluten, peanuts, tree nuts, nut products, or any nut byproducts. (COVID-19 vaccines are not manufactured in facilities that produce food products).
- No metals such as iron, nickel, cobalt, titanium, or rare earth alloys. They also do not have any manufactured products like microelectronics, electrodes, carbon nanotubes or other nanostructures, or nanowire semiconductors.
- No latex. The vial stoppers used to hold the vaccine also do not contain latex.
After the body produces an immune response, it discards all of the vaccine ingredients, just as it would discard any substance that cells no longer need. This process is a part of normal body functioning.
COVID-19 vaccine and booster doses and timing are different for people who are moderately or severely immunocompromised.
Vaccines for Immunocompromised
Pfizer-BioNTech and Moderna mRNA COVID-19 vaccines
mRNA vaccines use mRNA created in a laboratory to teach our cells how to make a protein—or even just a piece of a protein—that triggers an immune response inside our bodies. The mRNA from the vaccines is broken down within a few days after vaccination and discarded from the body.
Vaccine Schedule
Learn about the recommended timing between Pfizer-BioNTech COVID-19 vaccines and boosters for people:
COMIRNATY Name Change
After receiving U.S. Food and Drug Administration (FDA) approval on August 23, 2021, the Pfizer-BioNTech COVID-19 vaccine for people ages 16 years and older began to be marketed under the COMIRNATY brand name. The vaccine was also FDA approved for pre-teens and teens ages 12–15 on July 8, 2022. No change was made to the vaccine’s formula with the name change.
The Pfizer-BioNTech vaccine label remains for people ages 6 months–11 years since the vaccine is FDA authorized but not yet approved for these age groups.
Ingredients in Vaccine Formula for Children
The Pfizer-BioNTech COVID-19 vaccine for children ages 6 months–11 years contains only the following ingredients:
Type of Ingredient
Type of Ingredient
Messenger ribonucleic acid (mRNA)
Type of Ingredient
Messenger ribonucleic acid (mRNA)
- Nucleoside-modified mRNA encoding the viral spike (S) glycoprotein of SARS-CoV-2
Ingredient
- Nucleoside-modified mRNA encoding the viral spike (S) glycoprotein of SARS-CoV-2
Provides instructions the body uses to build a harmless piece of a protein from the virus that causes COVID-19. This protein causes an immune response that helps protect the body from getting sick with COVID-19 in the future.
Purpose
Provides instructions the body uses to build a harmless piece of a protein from the virus that causes COVID-19. This protein causes an immune response that helps protect the body from getting sick with COVID-19 in the future.
Type of Ingredient
Lipids (fats)
- 2[(polyethylene glycol (PEG))-2000]-N,N-ditetradecylacetamide
- 1,2-distearoyl-sn-glycero-3-phosphocholine
- Cholesterol (plant derived)
- ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate)
Ingredient
- 2[(polyethylene glycol (PEG))-2000]-N,N-ditetradecylacetamide
- 1,2-distearoyl-sn-glycero-3-phosphocholine
- Cholesterol (plant derived)
- ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate)
Work together to help the mRNA enter cells.
Purpose
Work together to help the mRNA enter cells.
Sugar and acid stabilizers
Type of Ingredient
Sugar and acid stabilizers
- Sucrose (table sugar)
- Tromethamine
- Tromethamine hydrochloride
Ingredient
- Sucrose (table sugar)
- Tromethamine
- Tromethamine hydrochloride
Work together to help keep the vaccine molecules stable while the vaccine is manufactured, frozen, shipped, and stored until it is ready to be given to a vaccine recipient.
Purpose
Work together to help keep the vaccine molecules stable while the vaccine is manufactured, frozen, shipped, and stored until it is ready to be given to a vaccine recipient.
Messenger ribonucleic acid (mRNA):
Nucleoside-modified mRNA encoding the viral spike (S) glycoprotein of SARS-CoV-2
Purpose
Provides instructions the body uses to build a harmless piece of a protein from the virus that causes COVID-19. This protein causes an immune response that helps protect the body from getting sick with COVID-19 in the future.
Lipids (fats):
- 2[(polyethylene glycol (PEG))-2000]-N,N-ditetradecylacetamide
- 1,2-distearoyl-sn-glycero-3-phosphocholine
- Cholesterol (plant derived)
- (4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate)
Purpose
Work together to help the mRNA enter cells.
Sugar and acid stabilizers:
- Dibasic sodium phosphate dihydrate
- Monobasic potassium phosphate
- Potassium chloride (common food salt)
- Sodium chloride (basic table salt)
- Sucrose (basic table sugar)
Purpose
Work together to help keep the vaccine molecules stable while the vaccine is manufactured, frozen, shipped, and stored until it is ready to be given to a vaccine recipient.
Ingredients in Vaccine Formula for Teens and Adults
The Pfizer-BioNTech COVID-19 vaccine for teens and adults ages 12 years and older contains only the following ingredients:
Type of Ingredient
Type of Ingredient
Messenger ribonucleic acid (mRNA)
Type of Ingredient
Messenger ribonucleic acid (mRNA)
- Nucleoside-modified mRNA encoding the viral spike (S) glycoprotein of SARS-CoV-2
Ingredient
- Nucleoside-modified mRNA encoding the viral spike (S) glycoprotein of SARS-CoV-2
Provides instructions the body uses to build a harmless piece of a protein from the virus that causes COVID-19. This protein causes an immune response that helps protect the body from getting sick with COVID-19 in the future.
Purpose
Provides instructions the body uses to build a harmless piece of a protein from the virus that causes COVID-19. This protein causes an immune response that helps protect the body from getting sick with COVID-19 in the future.
Type of Ingredient
Lipids (fats)
- 2[(polyethylene glycol (PEG))-2000]-N,N-ditetradecylacetamide
- 1,2-distearoyl-sn-glycero-3-phosphocholine
- Cholesterol (plant derived)
- ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate)
Ingredient
- 2[(polyethylene glycol (PEG))-2000]-N,N-ditetradecylacetamide
- 1,2-distearoyl-sn-glycero-3-phosphocholine
- Cholesterol (plant derived)
- ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate)
Work together to help the mRNA enter cells.
Purpose
Work together to help the mRNA enter cells.
Sugar and acid stabilizers
Type of Ingredient
Sugar and acid stabilizers
- Sucrose (table sugar)
- Tromethamine
- Tromethamine hydrochloride
Ingredient
- Sucrose (table sugar)
- Tromethamine
- Tromethamine hydrochloride
Work together to help keep the vaccine in good condition (molecules remain stable) while the vaccine is manufactured, frozen, shipped, and stored until it is ready to be given to a vaccine recipient.
Purpose
Work together to help keep the vaccine in good condition (molecules remain stable) while the vaccine is manufactured, frozen, shipped, and stored until it is ready to be given to a vaccine recipient.
Messenger ribonucleic acid (mRNA):
Nucleoside-modified mRNA encoding the viral spike (S) glycoprotein of SARS-CoV-2
Purpose
Provides instructions the body uses to build a harmless piece of a protein from the virus that causes COVID-19. This protein causes an immune response that helps protect the body from getting sick with COVID-19 in the future.
Lipids (fats):
- 2[(polyethylene glycol (PEG))-2000]-N,N-ditetradecylacetamide1
- 1,2-distearoyl-sn-glycero-3-phosphocholine
- Cholesterol (plant derived)
- ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate)
Purpose
Work together to help the mRNA enter cells.
Salts and sugar:
- Sucrose (table sugar)
- Tromethamine
- Tromethamine hydrochloride
Purpose
Work together to help keep the vaccine molecules stable while the vaccine is manufactured, frozen, shipped, and stored until it is ready to be given to a vaccine recipient.
Vaccine Schedule
Learn about the recommended timing between Moderna COVID-19 vaccines and boosters for people:
Spikevax Name Change
After receiving FDA approval on January 31, 2022, the Moderna COVID-19 vaccine for people ages 18 years and older began to be marketed under the Spikevax brand name. No change was made to the vaccine’s formula with the name change.
The Moderna vaccine name remains for people ages 6 months–17 years since the vaccine is authorized by the FDA but not yet approved for these age groups.
Ingredients
The Moderna COVID-19 vaccine for everyone ages 6 months and older contains only the following ingredients:
Type of Ingredient
Type of Ingredient
Messenger ribonucleic acid (mRNA)
Type of Ingredient
Messenger ribonucleic acid (mRNA)
- Nucleoside-modified mRNA encoding the viral spike (S) glycoprotein of SARS-CoV-2
Ingredient
- Nucleoside-modified mRNA encoding the viral spike (S) glycoprotein of SARS-CoV-2
Provides instructions the body uses to build a harmless piece of a protein from the virus that causes COVID-19. This protein causes an immune response that helps protect the body from getting sick with COVID-19 in the future.
Purpose
Provides instructions the body uses to build a harmless piece of a protein from the virus that causes COVID-19. This protein causes an immune response that helps protect the body from getting sick with COVID-19 in the future.
Type of Ingredient
Lipids (fats)
- PEG2000-DMG: 1,2-dimyristoyl-rac-glycerol, methoxypolyethylene glycol
- 1,2-distearoyl-sn-glycero-3-phosphocholine
- BotaniChol® (non-animal origin cholesterol)
- SM-102: heptadecane-9-yl 8-((2-hydroxyethyl) (6-oxo-6-(undecyloxy) hexyl) amino) octanoate
Ingredient
- PEG2000-DMG: 1,2-dimyristoyl-rac-glycerol, methoxypolyethylene glycol
- 1,2-distearoyl-sn-glycero-3-phosphocholine
- BotaniChol® (non-animal origin cholesterol)
- SM-102: heptadecane-9-yl 8-((2-hydroxyethyl) (6-oxo-6-(undecyloxy) hexyl) amino) octanoate
Work together to help the mRNA enter cells.
Purpose
Work together to help the mRNA enter cells.
Salt, sugar, acid stabilizers, and acid
Type of Ingredient
Salt, sugar, acid stabilizers, and acid
- Sodium acetate
- Sucrose (basic table sugar)
- Tromethamine
- Tromethamine hydrochloride
- Acetic acid (the main ingredient in white household vinegar)
Ingredient
- Sodium acetate
- Sucrose (basic table sugar)
- Tromethamine
- Tromethamine hydrochloride
- Acetic acid (the main ingredient in white household vinegar)
Work together to help keep the vaccine in good condition (molecules remain stable) while the vaccine is manufactured, frozen, shipped, and stored until it is ready to be given to a vaccine recipient.
Purpose
Work together to help keep the vaccine in good condition (molecules remain stable) while the vaccine is manufactured, frozen, shipped, and stored until it is ready to be given to a vaccine recipient.
Messenger ribonucleic acid (mRNA):
Nucleoside-modified mRNA encoding the viral spike (S) glycoprotein of SARS-CoV-2
Purpose
Provides instructions that the body uses to build a harmless piece of a protein from the virus that causes COVID-19. This protein causes an immune response that helps protect the body from getting sick with COVID-19 in the future.
Lipids (fats):
- PEG2000-DMG: 1,2-dimyristoyl-rac-glycerol, methoxypolyethylene glycol
- 1,2-distearoyl-sn-glycero-3-phosphocholine
- BotaniChol® (non-animal origin cholesterol)
- SM-102: heptadecane-9-yl 8-((2-hydroxyethyl) (6-oxo-6-(undecyloxy) hexyl) amino) octanoate
Purpose
Work together to help the mRNA enter cells.
Salt, sugar, acid stabilizers, and acid:
- Sodium acetate
- Sucrose (basic table sugar)
- Tromethamine
- Tromethamine hydrochloride
- Acetic acid (the main ingredient in white household vinegar)
Purpose
Work together to help keep the vaccine molecules stable while the vaccine is manufactured, frozen, shipped, and stored until it is ready to be given to a vaccine recipient.
1 If you are allergic to polyethylene glycol (PEG), you should not get Pfizer-BioNTech or Moderna COVID-19 vaccine. If you are allergic to polysorbate, you should not get Novavax or J&J/Janssen COVID-19 vaccine. Talk to your doctor about your options.
Comirnaty Information
Pfizer-BioNTech Fact Sheets (English) and FAQs
| Material | Audience | Vaccine Purpose | Vaccine Recipient Group | Last Updated |
|---|---|---|---|---|
| Pfizer-BioNTech COVID-19 Vaccine Presentations Wall Chart | Healthcare Providers | Bivalent Booster | All | August 31, 2022 |
| Fact Sheet | Healthcare Providers | Primary Series | 6 months through 4 years, maroon cap (must dilute) | August 31, 2022 |
| Dear Healthcare Provider Letter | Healthcare Providers | Primary Series | 6 months through 4 years, maroon cap (must dilute) | June 17, 2022 |
| Fact Sheet | Recipients and Caregivers | Primary Series | 6 months through 4 years of age | June 28, 2022 |
| Dear Healthcare Provider Letter | Healthcare Providers | Primary Series and Bivalent Booster | 5 years through 11 years of age, orange cap (must dilute) | October 12, 2022 |
| Fact Sheet | Healthcare Providers | Primary Series | 5 years through 11 years of age, orange cap (must dilute) | October 12, 2022 |
| Fact Sheet | Healthcare Providers | Bivalent Booster | 5 years through 11 years of age, orange cap (must dilute) | October 12, 2022 |
| Fact Sheet | Recipients and Caregivers | Primary Series and Booster | 5 years through 11 years of age | October 12, 2022 |
| Dear Healthcare Provider Letter | Healthcare Providers | Bivalent Booster | 12 years of age and older | August 31, 2022 |
| Fact Sheet | Healthcare Providers | Primary Series | 12 years of age and older, purple cap (PBS formulation, must dilute) | October 18, 2022 |
| Fact Sheet | Healthcare Providers | Primary Series | 12 years of age and older, gray cap (Tris formulation, no dilution) | August 31, 2022 |
| Fact Sheet | Healthcare Providers | Bivalent Booster | 12 years of age and older, gray border | October 12, 2022 |
| Fact Sheet | Recipients and Caregivers | Primary Series and Bivalent Booster | 12 years of age and older, purple and gray border | August 31, 2022 |
| Frequently Asked Questions on the Pfizer-BioNTech COVID-19 Vaccine | All | All | All | February 16, 2022 |
Who can get a COVID-19 vaccine
Everyone aged 5 (on or before 31 August 2022) and over can get a 1st and 2nd dose of the COVID-19 vaccine.
People aged 16 and over, and some children aged 12 to 15, can also get a booster dose.
People aged 5 and over who had a severely weakened immune system when they had their 1st or 2nd dose will be offered an additional primary dose (3rd dose) before any booster doses.
Some people, including those aged 50 years or over, those at higher risk or who are pregnant, and frontline health and social care workers, will be offered a seasonal booster (autumn booster).
Types of COVID-19 vaccine
The COVID-19 vaccines currently approved for use in the UK are:
- Moderna vaccine
- Pfizer/BioNTech vaccine
- Nuvaxovid vaccine (Novavax)
- Oxford/AstraZeneca vaccine (not currently available)
- Janssen vaccine (not currently available)
- Valneva vaccine (not currently available)
Which vaccine will I get?
You cannot usually choose which vaccine you have. If you book online, you’ll only be offered appointments for vaccines that are suitable for you.
Most people can have any of the COVID-19 vaccines, but some people are only offered certain vaccines.
For example:
- if you’re pregnant or under 40 you’ll usually be offered appointments for the Pfizer/BioNTech or Moderna vaccines
- if you’re under 18, you’ll only be offered the Pfizer/BioNTech vaccine
You should have the same vaccine for both your 1st and 2nd doses, unless you had serious side effects (such as a serious allergic reaction) after your 1st dose.
Most people will be offered a booster dose of the Pfizer/BioNTech vaccine or Moderna vaccine.
This means your booster dose may be different from the vaccine you had for your first 2 doses.
Public Advice
COVID-19 vaccines explained
COVID-19 questions answered
Advice on getting vaccinated
Delivering safe and effective vaccines
Regulation and policy
COVID-19 vaccines: product-by-product information
Latest vaccine news
All →
ユーザーがトピックに関連して検索するキーワード pfizer vaccine pfizer vaccine
kcau, sioux, city, iowa, news, weather, sports, abc, tim, seaman, local, siouxland, Pfizer Testing New RSV Vaccine
.
